Hypertrophic cardiomyopathy Dilated cardiomyopathy
Conditions
Interventions
Dilated cardiomyopathy group:NA
Hypertrophic cardiomyopathy group:NA
Sponsors
The second Affiliated Hosrital of Gannan Medical University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age range from 20 to 70 years old; 2. Patients with dilated cardiomyopathy meet the diagnostic criteria in the 2018 Chinese Guidelines for the Diagnosis and Treatment of Dilated Cardiomyopathy; 3. patients with hypertrophic cardiomyopathy meet the diagnostic and treatment guidelines for adult hypertrophic cardiomyopathy in China; 4. All patients have undergone cardiac magnetic resonance enhanced scanning; 5. All patients have complete clinical data and corresponding auxiliary examination results; 6. The patient and their family members have informed consent and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with liver, kidney, lung and other organ fibrosis diseases; 2. Patients with connective tissue diseases or malignant tumors; 3. Severe liver and kidney dysfunction; 4. Incomplete clinical data. 5. Patients with heart valve disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentrations of sK2 and CTRP3;HSP47 concentration;left ventricular ejection fraction, Left;left ventricular end-diastolic dimension, LVEDD;Right ventricular end-diastolic diameter, RVD;interventricular septum thickness, IVST;Left ventricular posterior wall thickness, LVPWT;left atrial diameter, LAD;Right atrial diameter, RAD; | — |
Countries
China
Contacts
Public ContactLu Ting
The second Affiliated Hosrital of Gannan Medical University
Outcome results
None listed